National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

CI-1033

 A substance being studied in the treatment of some types of cancer. CI-1033 blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called canertinib and canertinib dihydrochloride.



Previous Definitions:chronic obstructive pulmonary disease, chronic pain, chronic phase, chronic phase chronic myelogenous leukemia, CHS 828
Next Definitions:CI-958, CI-980, CI-994, cidofovir, cilengitide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov